Pnc Financial Services Group, Inc. Haemonetics Corp Transaction History

Pnc Financial Services Group, Inc.

  • $162 Billion
  • Q3 2025

A detailed history of Pnc Financial Services Group, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 4,118 shares of HAE stock, worth $302,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,118
Previous 4,639 11.23%
Holding current value
$302,631
Previous $346,000 42.2%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$47.67 - $78.17 $24,836 - $40,726
-521 Reduced 11.23%
4,118 $200,000
Q2 2025

Aug 08, 2025
BUY
$56.04 - $74.77 $616 - $822
11 Added 0.24%
4,639 $346,000
Q1 2025

May 09, 2025
SELL
$59.34 - $80.05 $247,744 - $334,208
-4,175 Reduced 47.43%
4,628 $294,000
Q4 2024

Feb 07, 2025
SELL
$71.16 - $93.38 $37,572 - $49,304
-528 Reduced 5.66%
8,803 $687,000
Q3 2024

Nov 08, 2024
BUY
$72.45 - $91.58 $6,448 - $8,150
89 Added 0.96%
9,331 $749,000
Q2 2024

Aug 09, 2024
SELL
$81.24 - $97.37 $64,504 - $77,311
-794 Reduced 7.91%
9,242 $764,000
Q1 2024

May 10, 2024
BUY
$71.24 - $85.35 $99,949 - $119,746
1,403 Added 16.25%
10,036 $856,000
Q4 2023

Feb 09, 2024
SELL
$80.59 - $92.61 $38,763 - $44,545
-481 Reduced 5.28%
8,633 $738,000
Q3 2023

Nov 13, 2023
BUY
$82.56 - $93.49 $79,752 - $90,311
966 Added 11.86%
9,114 $816,000
Q2 2023

Aug 11, 2023
BUY
$80.84 - $89.45 $36,701 - $40,610
454 Added 5.9%
8,148 $693,000
Q1 2023

May 15, 2023
BUY
$72.75 - $90.6 $58,563 - $72,933
805 Added 11.69%
7,694 $636,000
Q4 2022

Feb 10, 2023
SELL
$73.85 - $86.14 $29,613 - $34,542
-401 Reduced 5.5%
6,889 $541,000
Q3 2022

Nov 10, 2022
SELL
$63.3 - $78.66 $42,221 - $52,466
-667 Reduced 8.38%
7,290 $539,000
Q2 2022

Aug 12, 2022
SELL
$49.27 - $66.08 $238,713 - $320,157
-4,845 Reduced 37.85%
7,957 $518,000
Q1 2022

May 12, 2022
BUY
$43.77 - $63.22 $16,938 - $24,466
387 Added 3.12%
12,802 $809,000
Q4 2021

Feb 11, 2022
BUY
$49.55 - $74.59 $12,684 - $19,095
256 Added 2.11%
12,415 $658,000
Q3 2021

Nov 05, 2021
BUY
$57.6 - $70.59 $157,363 - $192,851
2,732 Added 28.98%
12,159 $858,000
Q2 2021

Aug 06, 2021
BUY
$51.81 - $118.56 $88,595 - $202,737
1,710 Added 22.16%
9,427 $628,000
Q1 2021

May 07, 2021
SELL
$111.01 - $139.48 $254,434 - $319,688
-2,292 Reduced 22.9%
7,717 $856,000
Q4 2020

Feb 12, 2021
SELL
$88.75 - $119.95 $14,555 - $19,671
-164 Reduced 1.61%
10,009 $1.19 Million
Q3 2020

Nov 06, 2020
BUY
$75.65 - $93.58 $237,767 - $294,121
3,143 Added 44.71%
10,173 $887,000
Q2 2020

Aug 07, 2020
SELL
$84.96 - $118.91 $16,482 - $23,068
-194 Reduced 2.69%
7,030 $629,000
Q1 2020

May 08, 2020
BUY
$74.34 - $121.82 $39,548 - $64,808
532 Added 7.95%
7,224 $719,000
Q4 2019

Feb 07, 2020
SELL
$114.37 - $129.46 $5.16 Million - $5.84 Million
-45,123 Reduced 87.08%
6,692 $768,000
Q3 2019

Nov 08, 2019
SELL
$117.16 - $138.52 $2.17 Million - $2.57 Million
-18,549 Reduced 26.36%
51,815 $6.54 Million
Q2 2019

Aug 09, 2019
BUY
$81.74 - $120.34 $5.16 Million - $7.6 Million
63,155 Added 876.06%
70,364 $0
Q1 2019

May 10, 2019
BUY
$83.25 - $102.12 $185,980 - $228,136
2,234 Added 44.9%
7,209 $0
Q4 2018

Feb 08, 2019
BUY
$90.66 - $116.63 $72,165 - $92,837
796 Added 19.05%
4,975 $497,000
Q3 2018

Nov 09, 2018
BUY
$89.96 - $114.58 $220,671 - $281,064
2,453 Added 142.12%
4,179 $0
Q2 2018

Aug 10, 2018
SELL
$71.53 - $95.75 $13,590 - $18,192
-190 Reduced 9.92%
1,726 $0
Q1 2018

May 11, 2018
SELL
$60.72 - $74.41 $3,400 - $4,166
-56 Reduced 2.84%
1,916 $0
Q4 2017

Feb 09, 2018
BUY
$44.96 - $58.99 $2,158 - $2,831
48 Added 2.49%
1,972 $0
Q3 2017

Nov 13, 2017
BUY
$40.38 - $44.87 $77,691 - $86,329
1,924
1,924 $0

Others Institutions Holding HAE

# of Institutions
339
Shares Held
50.2M
Call Options Held
666K
Put Options Held
395K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email